IMUP and GPRC5A: two newly identified risk score indicators in pancreatic ductal adenocarcinoma
Abstract Background Pancreatic cancer has been a threateningly lethal malignant tumor worldwide. Despite the promising survival improvement in other cancer types attributing to the fast development of molecular precise medicine, the current treatment situation of pancreatic cancer is still woefully...
Guardado en:
Autores principales: | Rong Wei, Guoye Qi, Zixin Zeng, Ningning Shen, Ziyue Wang, Honghong Shen, Lifang Gao, Chen Song, Wenxia Ma, Chen Wang |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
BMC
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/7c274beae6024eb7b86f7592cf8dc465 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Identification of Hub Genes in Pancreatic Ductal Adenocarci-noma Using Bioinformatics Analysis
por: Congcong Wang, et al.
Publicado: (2021) -
Long noncoding RNA MIAT inhibits the progression of diabetic nephropathy and the activation of NF-κB pathway in high glucose-treated renal tubular epithelial cells by the miR-182-5p/GPRC5A axis
por: Dong Qianlan, et al.
Publicado: (2021) -
Identification of a novel metabolism-related gene signature associated with the survival of bladder cancer
por: Xiaotao Li, et al.
Publicado: (2021) -
Potential Prognostic Biomarkers of NIMA (Never in Mitosis, Gene A)-Related Kinase (NEK) Family Members in Breast Cancer
por: Gangga Anuraga, et al.
Publicado: (2021) -
Independent prognostic genes and mechanism investigation for colon cancer
por: Li,Chunsheng, et al.
Publicado: (2018)